Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 786586 | 7 pages | https://doi.org/10.1155/2014/786586

Phytochemistry and Preliminary Assessment of the Antibacterial Activity of Chloroform Extract of Amburana cearensis (Allemão) A.C. Sm. against Klebsiella pneumoniae Carbapenemase-Producing Strains

Academic Editor: Ulysses Paulino Albuquerque
Received24 Nov 2013
Revised07 Jan 2014
Accepted10 Jan 2014
Published17 Mar 2014

Abstract

The chloroform extract of the stem bark of Amburana cearensis was chemically characterized and tested for antibacterial activity.The extract was analyzed by gas chromatography and mass spectrometry. The main compounds identified were 4-methoxy-3-methylphenol (76.7%), triciclene (3.9%), α-pinene (1.0%), β-pinene (2.2%), and 4-hydroxybenzoic acid (3.1%). Preliminary antibacterial tests were carried out against species of distinct morphophysiological characteristics: Escherichia coli, Salmonella enterica Serotype Typhimurium, Pseudomonas aeruginosa, Staphylococcus aureus, Listeria monocytogenes, and Bacillus cereus. The minimum inhibitory concentration (MIC) was determinate in 96-well microplates for the chloroform extract and an analogue of themain compound identified, which was purchased commercially.We have shown that plant’s extract was only inhibitory (but not bactericidal) at the maximum concentration of 6900 μg/mL against Pseudomonas aeruginosa and Bacillus cereus. Conversely, the analogue 2-methoxy-4-methylphenol produced MICs ranging from215 to 431 μg/mL against all bacterial species.New antibacterial assays conducted with such chemical compound against Klebsiella pneumoniae carbapenemase-producing strains have shown similarMICresults and minimumbactericidal concentration (MBC) of 431 μg/mL.We conclude that A. cearensis is a good source of methoxy-methylphenol compounds,which could be screened for antibacterial activity againstmultiresistant bacteria fromdifferent species

1. Introduction

Amburana cearensis (Allemão) A.C. Sm. (Fabaceae) is a native plant from Brazilian semiarid region widely used in folk medicine to treat nervous disorders, headaches, asthma, sinusitis, bronchitis, flu, and rheumatic pain, with the stem bark and seeds commonly being consumed as tea or infusion preparations [13]. The stem bark is rich in coumarin (1,2-benzopyrone), whose pharmacological properties include anti-inflammatory, antinociceptive, and bronchodilator effects [47]. Indeed, four new compounds (p-hydroxybenzoic acid, aiapin, and two stereoisomers of o-coumaric acid glycoside) were recently identified, showing plants’ repertory of potential bioactive substances [8]. However, although A. cearensis has been broadly used in treatment of respiratory infections, only a few studies report antimicrobial activity in plants’ extracts [9, 10], and, therefore, its potential as a source of new antimicrobials was not fully investigated.

The spread of multidrug resistance among bacteria from various sources [1116] has made natural product researchers increase their effort on screening plant extracts for compounds with broad spectrum of antimicrobial activity. For example, Tragia involucrata L., Citrus acida (Roxb. Hook.f.), and Aegle marmelos (L.) Correa ex Roxb. showed wide inhibitory action against several multidrug-resistant human pathogens, particularly, Burkholderia pseudomallei and Staphylococcus aureus, which was related to the high contents of phenolic or polyphenolic compounds in methanol extracts [17, 18]. Likewise, recent antibacterial assays with stem bark ethanol extracts of A. cearensis have shown growth inhibition of a broad range of pathogens of veterinary interest [10]. In particular, hospital-acquired infections caused by Klebsiella pneumoniae (Enterobacteriaceae) have increased in recent years due to emergence of carbapenemase- producing strains [19, 20]. These bacteria are capable of hydrolyzing carbapenems, penicillins, cephalosporins, and aztreonam [21], and, therefore, the search for new therapeutics is forthcoming.

Here, a preliminary assessment of the antibacterial activity of A. cearensis chloroform extracts against human clinical isolates of K. pneumoniae carbapenemase-producing strains was conducted. Moreover, the plants’ extract was chemically characterized and an analogue of the major compound identified was also tested against bacteria. Although the chemical composition of plant extracts varies under influence of seasonal and climatic conditions [22], in the present study, we report A. cearensis as a new source of methoxy-methylphenol compounds with antibacterial activity. These are phenol derivatives with potential applications as antiseptics and biocides. These data are discussed in light of previous studies.

2. Material and Methods

2.1. Collection and Botanical Identification

The stem bark of A. cearensis was collected in the municipality of Salgueiro, Pernambuco, Brazil (latitude 08°04′27′′ south and longitude 39°07′09′′ west). The plant’s identification was made by comparing the aerial parts with exsiccate samples (voucher number 46090) deposited in the collection of Vasconcelos Sobrinho Herbarium, Department of Biology, Federal Rural University of Pernambuco, under the care of Dr. Suzene Izidio da Silva.

2.2. Plant Extract

Fresh plant material was collected and dried in oven at a temperature range of 45°C to 50°C for 48 h. The dried material was ground in a blade mill to obtain a fine homogeneous powder. This material was weighed and extracted by maceration using chloroform (P.A.) as solvent extractor in the ratio of 1 : 3 (w : v). The resulting mixture remained for 48 hours under agitation every two hours. The extract was filtered and concentrated in a rotary evaporator under reduced pressure at a temperature of 45°C for complete solvent removal. Stock solutions were prepared with extracts using dimethyl sulfoxide (DMSO) as solvent (100 mg/mL), which were kept in a refrigerator at −20°C until use [23].

2.3. Analysis by Gas Chromatography Coupled to Mass Spectrometry (GS/MS)

The plant extract was analyzed by GS/MS using a Varian 431-GC chromatograph coupled to a Varian 220-MS mass spectrometer, equipped with a J & W Scientific DB5 fused silica capillary column (). The temperature of the injector and detector was set at 260°C with the furnace temperature programmed in a range of 60–240°C at 3°C/min. The mass spectra were obtained with a 70 eV electron impact, 0.84 scan/sec m/z 40–550. The carrier gas used was helium at a flow rate of 1 mL/min. A stock solution of 2 mg/mL was prepared and 1.0 L was injected for analyses. The identification of the constituents was carried out by comparison with previously reported values of retention indices, obtained by coinjection of oil samples and C11–C24 linear hydrocarbons and calculated using the van Den Dool and Kratz equation [24], by direct comparison of the spectra with spectra stored in libraries of equipment (NIST21 and NIST107) as well as with the spectra and retention times of authentic compounds reported previously in the literature for comparison. Subsequently, the MS acquired for each component was matched with those stored in the NIST21, NIST107 mass spectral library of the GC-MS system and with other published mass spectral data [25].

2.4. Microorganism and Growth Conditions

Preliminary assessment of antibacterial activity was conducted with bacteria of distinct morphophysiological characteristics, such as Escherichia coli (facultative anaerobe, gram-negative, nonencapsulated, extracellular bacteria, Enterobacteriaceae), Salmonella enterica Serotype Typhimurium (facultative anaerobe, gram-negative, nonencapsulated, intracellular bacteria, Enterobacteriaceae), Pseudomonas aeruginosa (aerobe, gram-negative, extracellular bacteria, non-Enterobacteriaceae), Staphylococcus aureus (facultative anaerobe, gram-positive, non-spore-forming, extracellular bacteria), Listeria monocytogenes (facultative anaerobe, gram-positive, non-spore-forming, intracellular bacteria),and Bacillus cereus (aerobe, gram-positive, spore-forming, extracellular bacteria) belonging to the collection of the Laboratory of Microbiology and Immunology of Federal Rural University of Pernambuco (UFRPE). Klebsiella pneumoniae carbapenem-resistant strains (KPC) were obtained from human clinical cases and kindly provided by Dr. Marcia Moraes (University of Pernambuco). Single colonies from fresh cultures were streaked in tubes containing Brain Heart Infusion Agar after growth (37°C/18–24 h) and kept at 8°C until use.

2.5. Determination of the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

The MIC of the plant extract was determined by the microdilution method [34] in 96-well plates at concentrations ranging from 6.7 to 6900 µg/mL. In addition, the analogue 2-methoxy-4-methylphenol of the main compound identified in plant extracts (4-methoxy-3-methylphenol) was purchased commercially (Sigma) and also investigated. The density of the bacterial suspension was adjusted to approximately 105 CFU/mL, and the results were read after an incubation period of 24 hours at 37°C. The MIC was the lowest concentration causing inhibition of visible growth. In this case, aliquots of 0.1 mL were transferred to plates containing Mueller-Hinton agar. The minimum bactericidal concentration (MBC) was considered the lowest concentration that resulted in no growth after incubation for 24 h at 37°C. All assays were performed in duplicate.

3. Results and Discussion

The Brazilian floras are worldwide known as a source of biologically active compounds with biodegradable properties, and, therefore, screening of plant extracts is often a first step procedure for isolation of phytochemicals [23]. However, studies that correlate antibacterial activity of extracts to the presence of specific compounds are rare. For instance, ethanol extracts of the stem bark of A. cearensis were reported to be inhibitory against Staphylococcus epidermidis, S. aureus, Klebsiella spp., Salmonella spp., Enterobacter aerogenes, Streptococcus pyogenes, Proteus mirabilis, Pseudomonas aeruginosa, and Shigella flexneri, but no chemical characterization was performed [10]. Here, we report the phytochemistry and preliminary assessment of A. cearensis chloroform extracts as a source of novel antimicrobials against multiresistant Klebsiella strains.

The GC/MS data showed a major peak at the retention time of 7.8 min with relative concentration of 76.7% (Figure 1). The interpretation of the mass spectra in comparison with spectra reported in the literature led to identification of the benzenoid 4-methoxy-3-methylphenol. Other compounds included tricyclene (3.9%), -pinene (1.0%), -pinene (2.2%), and 4-hydroxybenzoic acid (3.1%). The complete list of compounds identified in plants’ extract is reported in Table 1. Several compounds have been identified in the bark of A. cearensis, such as trans -3,4-methyl dimetoxicinamato, cis-3,4-dimethoxy-methyl cinnamate, 3-methoxy-4-hydroxy-methyl cinnamate, 4-hydroxy-methyl benzoate, 3,4-dihydroxy methyl benzoate, 3-hydroxy-4-methoxy methyl benzoate, catechol, guaiacol, a-ethoxy-p-cresol, benzenemethanol 4-hydroxy, 4-methoxy-methylphenol, 2,3-dihydrobenzofuran, and anthraquinone (chrysophanol), with predominance of coumarins being often reported [35].


CompoundsaRelative area (%)RIbRIc

Tricyclene3.9919921
α-Pinene1.0931932
β-Pinene2.2974974
6,10-Dodecatrien-1-ol, 3,7,11-trimethyl2.3d
4-Methoxy-3-methylphenol76.7d
Terpinolene0.310871088
1,3,8-p-Menthatriene0.511071108
4-Hydroxybenzoic acid3.1d
Longifolene1.714051407
cis-Muurolo-4(14),5-diene3.214621465

Total94.9

Compounds are listed in order of their elution from a DB-5 column; bRI = retention indices relative to C7–C30   -alkanes; cRI = retention indices from the literature. dIdentified by direct comparison of the spectra with spectra stored in libraries of equipment as well as with the spectra and retention times of authentic compounds reported previously in the literature for comparison.

The initial screening for antibacterial activity has shown that plants’ chloroform extract was only inhibitory against P. aeruginosa and B. cereus at the highest concentration of 6900 µg/mL (Table 2). P. aeruginosa is responsible for different etiological processes in immunocompetent and immunocompromised patients in hospitals, whereas B. cereus is an opportunistic pathogen [36, 37]. On the other hand, the analogue compound 2-methoxy-4-methylphenol showed broad spectrum activity against all bacteria tested (Table 3). Indeed, the MIC ranged from 215 to 431 µg/mL against K. pneumoniae carbapenemase-producing strains being also bactericidal at 431 µg/mL (Table 3). The carbapenems imipenem, meropenem, and ertapenem are often used as last therapeutic choices against gram-negative multidrug-resistant bacteria [38]. Moreover, these bacteria usually show resistance to aminoglycosides and fluoroquinolones due to the presence of gene gnr and [39]. Thus, the risk of nosocomial infections is higher for patients in hospital’s intensive care units [40, 41].


Bacterial species Chloroform extract 2-Methoxy-4-methylphenolCiprofloxacin
MIC*MBCMICMBCMICMBC
µg/ mL

Salmonella enterica Typhimurium215431 <6.7 <6.7
Escherichia coli 215 431 <6.7<6.7
Pseudomonas aeruginosa >6900431 >6900 <6.7<6.7
Bacillus cereus >6900431 3450 <6.7 107
Listeria monocytogenes 215 862 <6.7<6.7
Staphylococcus aureus 215 862 <6.7<6.7

MIC: minimum inhibitory concentration; MBC: minimum bactericidal concentration.

K. pneumonia strains 2-Methoxy-4-methylphenolCiprofloxacin
MIC*MBCMICMBC
(µg/mL)

KPC 201215 431 <6.7<6.7
KPC 199215 431 <6.7<6.7
KPC +215 431 <6.7 215
KPC 278215 431 <6.7 431

MIC: minimum inhibitory concentration; MBC: minimum bactericidal concentration.

According to PubChem Compound Database, 4-methoxy-3-methylphenol is also known as 14786-82-4, AG-D-93185, NSC168522, AC1L6RKC, SureCN263095, and 4-methoxy-3-methylphenol [42]. Although anticancer assays were previously carried out with the compound, it was reported to be inactive against tumor model L1210 leukemia in mice [42]. While we were not aware of previous antimicrobial studies conducted with 4-methoxy-3-methylphenol, we hypothesize that the action mechanism of the molecule against bacteria is possibly due to 3-methylphenol compound (m-cresol) well known as an oxidizing agent [43]. Yet, m-cresol is a methyl derivative of phenol that has been used as precursor of amylmetacresol present in commercial antiseptic formulation.

The array of chemical compounds in A. cearensis extracts varies despite the type of solvent used (Table 4). Accordingly, we have shown that chloroform extracts of A. cearensis are good sources of methoxy-methylphenol compounds with antibacterial activity against several bacterial species and clinical isolates of multidrug-resistant K. pneumonia. Thus, the plants’ chloroform extract could be exploited as a source of antiseptics or biocides against drug-resistant bacteria from different species.


Part used Solvent Secondary metabolites Antibacterial activityReference

Stem barkEthanolNot reportedStaphylococcus epidermidis [9]
Stem barkEthanolNot reportedCocci strains, Enterobacteria, non-fermenting bacteria[10]
Stem bark and leaves Ethanol Anthocyanins, anthocyanidins, flavones, chalcones, aurones, leucoanthocyanidinsNot reported[11, 13]
Seeds Butanol and hydroethanol Flavonoids, proanthocyanidins, anthocyanins, carotenoidsNot reported[26]
Aerial parts and xylopodium Ethanol Protocatechuic acid, vanillic acid, coumarin, amburosideNot reported[27]
Resin Methanol and chloroform Chalcone, 2′,4,4′-trihydroxy chalcone (isoliquiritigenin a) (1), 2′,4′, dihydroxy-3′,4′-methoxychalcone (2), 7,8,3′,4′-tetramethoxy isoflavone, 2′,4,4′-trihydroxy (isoliquiritigenin) (1);
2′,4′,dihydroxy-3′,4′-methoxy (2),7,8,3′,4′-tetramethoxy isoflavone
Not reported[28]
Stem bark Ethanol Coumarin and phenolic compounds (isokaempferide and amburoside)Not reported[29]
Wood powder Hydroethanol 1-Dodecanol; 2-ethyl-hexane acid; dihydrocoumarin; coumarin (1,2- benzopyrone)Not reported[30]
Stem bark Ethanol Isoflavonoid (afromorsin)Not reported[31]
Stem bark Hexane and chloroformCumarina Coumarin (1,2 - benzopirona) (1,2-benzopyrone)Not reported[32]
Trunk barkEthanolCoumarin and vanillic acid Not reported[33]

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors thank Dr. Suzene Izidio da Silva for botanical identification and Dr. Marcia Moraes for providing the Klebsiella strains used in the present study.

References

  1. U. P. de Albuquerque and R. F. de Oliveira, “Is the use-impact on native caatinga species in Brazil reduced by the high species richness of medicinal plants?” Journal of Ethnopharmacology, vol. 113, no. 1, pp. 156–170, 2007. View at: Publisher Site | Google Scholar
  2. I. G. C. Bieski, F. Rios Santos, R. M. De Oliveira et al., “Ethnopharmacology of medicinal plants of the pantanal region (Mato Grosso, Brazil),” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 272749, 36 pages, 2012. View at: Publisher Site | Google Scholar
  3. G. M. Conceição, A. C. Ruggieri, M. F. V. Araújo et al., “Medicinal plants of the Cerrado: sales, use and indication provided by the healers and sellers,” Scientia Plena, vol. 7, pp. 1–6, 2011. View at: Google Scholar
  4. J. R. S. Hoult and M. Payá, “Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential,” General Pharmacology, vol. 27, no. 4, pp. 713–722, 1996. View at: Publisher Site | Google Scholar
  5. L. K. A. M. Leal, M. E. Matos, F. J. A. Matos, R. A. Ribeiro, F. V. Ferreira, and G. S. B. Viana, “Antinociceptive and antiedematogenic effects of the hydroalcoholic extract and coumarin from Torresea cearensis Fr. All,” Phytomedicine, vol. 4, no. 3, pp. 221–227, 1997. View at: Google Scholar
  6. L. K. A. M. Leal, A. A. G. Ferreira, G. A. Bezerra, F. J. A. Matos, and G. S. B. Viana, “Antinociceptive, anti-inflammatory and bronchodilator activities of Brazilian medicinal plants containing coumarin: a comparative study,” Journal of Ethnopharmacology, vol. 70, no. 2, pp. 151–159, 2000. View at: Publisher Site | Google Scholar
  7. L. K. A. M. Leal, F. G. Oliveira, J. B. Fontenele, M. A. D. Ferreira, and G. S. B. Viana, “Toxicological study of the hydroalcoholic extract from Amburana cearensis in rats,” Pharmaceutical Biology, vol. 41, no. 4, pp. 308–314, 2003. View at: Publisher Site | Google Scholar
  8. K. M. Canuto, E. R. Silveira, and A. M. E. Bezerra, “Phytochemical analysis of cultivated specimens of cumaru (Amburana cearensis A. C. Smith),” Quimica Nova, vol. 33, no. 3, pp. 662–666, 2010. View at: Google Scholar
  9. A. L. Gonçalves, Study of antimicrobial activity of some indigenous medicinal trees with potential for conservation/ restoration of tropical forests [Ph.D. thesis], Ciências Biológicas, Universidade Paulista, São Paulo, Brasil, 2007.
  10. M. C. A. de Sá, R. M. Peixoto, C. C. Krewer, J. R. G. da Silva Almeida, A. C. Vargas, and M. M. da Costa, “Antimicrobial activity of caatinga biome ethanolic plant extract against gram negative and positive bacteria,” Revista Brasileira de Ciência Veterinária, vol. 18, pp. 62–66, 2011. View at: Google Scholar
  11. J. V. Lima-Filho, L. V. Martins, D. C. O. Nascimento et al., “Zoonotic potential of multidrug-resistant extraintestinal pathogenic Escherichia coli obtained from healthy poultry carcasses in Salvador,” Brazilian Journal of Infectious Disease, vol. 17, pp. 54–61, 2013. View at: Google Scholar
  12. P. Cos, A. J. Vlietinck, D. V. Berghe, and L. Maes, “Anti-infective potential of natural products: how to develop a stronger in vitro ‘proof-of-concept’,” Journal of Ethnopharmacology, vol. 106, no. 3, pp. 290–302, 2006. View at: Publisher Site | Google Scholar
  13. L. G. P. R. Souza, Ethnobotanical phytochemical studies and researches of the garden of medicinal plants [Ph.D. thesis], Univ. Federal de Campina Grande, Paraíba, Brasil, 2011.
  14. J. E. C. Batista, E. L. Ferreira, D. C. O. Nascimento et al., “Antimicrobial resistance and detection of the mecA gene besides enterotoxin-encoding genes among coagulase-negative Staphylococci isolated from clam meat of Anomalocardia brasiliana,” Foodborne Pathogens and Disease, vol. 10, no. 12, pp. 1044–1049, 2013. View at: Google Scholar
  15. R. M. P. Antunes, E. O. Lima, M. S. V. Pereira et al., “Antimicrobial activity, “in vitro” and determination of the minimum inhibitory concentration (MIC) of phytochemicals and synthetic compounds against bacteria and yeast fungi,” in Leaves of Eugenia Uniflora (Pitanga): Pharmacobotanical, Chemical and Pharmacological Properties, M. T. Auricchio and E. M. Bacchi, Eds., vol. 62 of Revista do Instituto Adolfo Lutz, pp. 55–61, 2003. View at: Google Scholar
  16. J. A. Interaminense, D. C. O. Nascimento, R. F. Ventura et al., “Recovery and screening for antibiotic susceptibility of potential bacterial pathogens from the oral cavity of shark species involved in attacks on humans in Recife, Brazil,” Journal of Medical Microbiology, vol. 59, no. 8, pp. 941–947, 2010. View at: Publisher Site | Google Scholar
  17. S. R. Perumal, J. Manikandan, and M. Al Qahtani, “Evaluation of aromatic plants and compounds used to fight multidrug resistant infections,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 525613, 17 pages, 2013. View at: Publisher Site | Google Scholar
  18. M. E. Van Der Berg, “Medicinal plants in the Amazon—contribution to systematic knowledge,” Museu Paraense Emílio Goeldi, pp. 50–198, 1982. View at: Google Scholar
  19. J. Walther-Rasmussen and N. Høiby, “OXA-type carbapenemases,” Journal of Antimicrobial Chemotherapy, vol. 57, no. 3, pp. 373–383, 2006. View at: Publisher Site | Google Scholar
  20. R. P. Adams, Identification of Essential Oil Components By Gas Chromatography/Mass Spectrometry, Allured Publishing, Carol Stream, Ill, USA, 2007.
  21. R. Zhang, L. Yang, C. C. Jia, W. Z. Hong, and G.-X. Chen, “High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression,” Journal of Medical Microbiology, vol. 57, no. 3, pp. 332–337, 2008. View at: Publisher Site | Google Scholar
  22. A. B. Silva, T. Silva, E. S. Franco et al., “Antibacterial activity, chemical composition, and cytotoxicity of leaf's essential oil from Brazilian pepper tree (Schinus terebinthifolius, Raddi),” Brazilian Journal of Microbiology, vol. 41, no. 1, pp. 158–163, 2010. View at: Google Scholar
  23. J. V. Lima-Filho and R. A. Cordeiro, “In vitro and in vivo antibacterial and antifungal screening of natural plant products: prospective standardization of basic methods,” in Methods and Techniques in Ethnobiology and Ethnoecology, U. P. Albuquerque, L. V. F. Cruz da Cunha, R. F. P. Lucena et al., Eds., pp. 275–291, Springer Protocols Handbooks, 2014. View at: Google Scholar
  24. H. van Den Dool and P. Dec. Kratz, “A generalization of the retention index system including linear temperature programmed gas-liquid partition chromatography,” Journal of Chromatography A, vol. 11, pp. 463–471, 1963. View at: Google Scholar
  25. R. P. Adams, Identification of Essential Oil Components By Gas Chromatograpy/Mass Spectroscopy, USDA, Allured Publishing Corporation, Carol Stream, IIl, USA, 1995.
  26. N. O. Rego Jr., L. G. Fernandez, R. D. Castro et al., “Bioactive compounds and antioxidant activity of crude extract of brushwood vegetable species,” Brazilian Journal of Food Technology, vol. 14, pp. 50–57, 2011. View at: Google Scholar
  27. K. M. Canuto, E. R. Silveira, A. M. E. Bezerra et al., “Use of young plants of A. cearensis AC Smith: Alternatives for Preservation and Economic Exploitation and Economic exploitation of Species,” Embrapa Semi-árido, Petrolina, Doc. 208, p. 24, 2008. View at: Google Scholar
  28. P. N. Bandeira, S. S. de Farias, T. L. G. Lemos et al., “New derivatives of isoflavone and other flavonoids from the resin Amburana cearensis,” Journal of the Brazilian Chemistry Society, vol. 22, no. 2, pp. 372–375, 2011. View at: Google Scholar
  29. L. K. A. M. Leal, Contribution to the validation of the medicinal use of Amburana cearensiis (Cumaru): pharmacological studies with isokaempferide and amburoside [Ph.D. thesis], Universidade Federal do Ceará, Fortaleza, Brazil, 2006.
  30. M. M. Leão, Influence of treatment chemical composition of wood amburana (Amburana cearensis), balm (Myroxylon balsamum) and carvalho (Quercus sp.) and the impact on the aroma of rum from a model solution [Ph.D. thesis], Escola superior de Agricultura Luiz de Queiroz, Universidade de São Paulo, São Paulo, Brasil, 2006.
  31. A. A. Lopes, Evaluation of anti-inflammatory and antioxidant capsules of standardized dry layer and the isoflavone afrormosina obtained from Amburana cearensis AC SMITH [Ph.D. thesis], Universidade Federal do Ceará, Fortaleza, Brasil, 2010.
  32. M. D. G. V. Marinho, A. G. De Brito, K. D. A. Carvalho et al., “Amburana cearensis and coumarin immunomodulate the levels of antigen-specific antibodies in ovalbumin sensitized BALB/c mice,” Acta Farmaceutica Bonaerense, vol. 23, no. 1, pp. 47–52, 2004. View at: Google Scholar
  33. L. K. A. M. Leal, T. M. Pierdoná, J. G. S. Góes et al., “A comparative chemical and pharmacological study of standardized extracts and vanillic acid from wild and cultivated Amburana cearensis A.C. Smith,” Phytomedicine, vol. 18, no. 2-3, pp. 230–233, 2011. View at: Publisher Site | Google Scholar
  34. E. W. Koneman, S. D. Allen, W. M. Janda et al., Microbiological Diagnosis: Text and Color Atlas, MEDSI, Rio de Janeiro, Brasil, 5th edition, 2008.
  35. G. Negri, A. F. M. Oliveira, M. L. F. Salatino, and A. Salatino, “Chemistry of the stem bark of Amburana cearensis (Allemão) (A.C.SM.),” Revista Brasileira de Plantas Medicinais, vol. 6, no. 3, pp. 1–4, 2004. View at: Google Scholar
  36. P. Onguru, A. Erbay, H. Bodur et al., “Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections,” Journal of Korean Medical Science, vol. 23, no. 6, pp. 982–987, 2008. View at: Publisher Site | Google Scholar
  37. P. C. B. Turnbull, K. Jorgensen, J. M. Kramer, R. J. Gilbert, and J. M. Parry, “Severe clinical conditions associated with Bacillus cereus and the apparent involvement of exotoxins,” Journal of Clinical Pathology, vol. 32, no. 3, pp. 289–293, 1979. View at: Google Scholar
  38. A. C. Rodloff, E. J. C. Goldstein, and A. Torres, “Two decades of imipenem therapy,” Journal of Antimicrobial Chemotherapy, vol. 58, no. 5, pp. 916–929, 2006. View at: Publisher Site | Google Scholar
  39. I. Chmelnitsky, S. Navon-Venezia, J. Strahilevitz, and Y. Carmeli, “Plasmid-mediated qnrB2 and carbapenemase gene blaKPC-2 carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 8, pp. 2962–2965, 2008. View at: Publisher Site | Google Scholar
  40. C. L. Poh, S. C. Yap, and M. Yeo, “Pulsed-field gel electrophoresis for differentiation of hospital isolates of Klebsiella pneumoniae,” Journal of Hospital Infection, vol. 24, no. 2, pp. 123–128, 1993. View at: Publisher Site | Google Scholar
  41. T. Ben-Hamouda, T. Foulon, A. Ben-Cheikh-Masmoudi, C. Fendri, O. Belhadj, and K. Ben-Mahrez, “Molecular epidemiology of an outbreak of multiresistant Klebsiella pneumoniae in a Tunisian neonatal ward,” Journal of Medical Microbiology, vol. 52, no. 5, pp. 427–433, 2003. View at: Publisher Site | Google Scholar
  42. National Center for Biotechnology Information, http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=297394#x299.
  43. E. A. Cooper, “On the relationship of phenol and m-cresol to proteins: a contribution to our knowledge of the mechanism of disinfection,” Biochemical Journal, vol. 6, pp. 362–387, 1912. View at: Google Scholar

Copyright © 2014 Mirivaldo Barros Sá et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1703 Views | 707 Downloads | 7 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.